The gut dysbiosis and plasma lipid metabolisms signatures in children with active tuberculosis

The gut dysbiosis and plasma lipid metabolisms signatures in children with active tuberculosis

Publication date: Jul 09, 2025

Linear discriminant effect size analysis (LEfSe) was performed to obtain a linear discriminant analysis (LDA) score histogram .Statistical analysis was performed using R (version 4. 3.1). The alpha diversity was evaluated using the Shannon index and Observed species index, and compared between groups using the Wilcoxon rank-sum test. Normality test of the data was performed using the Shapiro-Wilk test, and non-parametric data are presented as the median and interquartile range. Significant differences in community composition were determined using permutational multivariate analysis of variance (PERMANOVA). Based on the distribution, either a Students t-test (for normally distributed data) or a Wilcoxon rank-sum test (for non-normally distributed data) was used to compare two groups. Samples were then vortexed (10 min intervals, 30 min at room temperature) and processed using a filter screen (70 m). To evaluate the risk of clinical comorbidities in children with TB, binary logistic regression analysis was performed, comparing TB patients with non-TB infectious disease controls.

Concepts Keywords
June Based
Novogene Clinical
Polyvinylpyrrolidone Collected
Tuberculosis Differences
Volcano Lipid
Min
Mtb
Performed
Plasma
Reads
Sequence
Stool
Tb
Test
Version

Semantics

Type Source Name
disease IDO quality
disease IDO algorithm
disease IDO reagent
drug DRUGBANK Phosphate ion
drug DRUGBANK Edetic Acid
disease IDO history
disease IDO bacteria
drug DRUGBANK Cycloserine
disease MESH infectious diseases
pathway REACTOME Release
disease IDO assay
disease MESH abnormalities
disease MESH malnutrition
disease MESH weight loss
pathway KEGG Tuberculosis
disease MESH tuberculosis
disease MESH dysbiosis
drug DRUGBANK Flunarizine
drug DRUGBANK Aspartame
disease IDO process
pathway REACTOME Infectious disease
disease IDO infectious disease

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *